Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06167330
Other study ID # U1111-1296-2782
Secondary ID X23-0202 & 2023/
Status Recruiting
Phase N/A
First received
Last updated
Start date December 18, 2023
Est. completion date December 18, 2027

Study information

Verified date February 2024
Source Neuroscience Research Australia
Contact James H McAuley, PhD
Phone +61293991266
Email j.mcauley@neura.edu.au
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to investigate the effectiveness of two rehabilitation programs for individuals who have undergone amputations and are experiencing phantom limb pain. The main question it aims to answer is: - In individuals who have undergone amputations and are experiencing phantom limb pain, what is the effectiveness of a progressive rehabilitation program compared to a treatment program consisting of transcutaneous electrical nerve stimulation and cranial electrical stimulation on reducing pain intensity and pain interference? A total of 208 participants will be randomized into two groups: progressive rehabilitation program and stimulation devices. The progressive rehabilitation program includes pain science education, sensory training, and left/right judgements, imagined movements and mirror therapy. The treatment program for the group receiving the stimulation devices includes transcutaneous electrical nerve stimulation and cranial electrical stimulation. Both interventions will be delivered via eight, up to 1-hour telehealth sessions. Outcome measures will be assessed at baseline and weeks 12, 24 and 52.


Recruitment information / eligibility

Status Recruiting
Enrollment 208
Est. completion date December 18, 2027
Est. primary completion date December 18, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Experiencing phantom limb pain for at least three months. - Report at least one episode of phantom limb pain in the previous week. - Report at least 4 points in pain intensity over the previous 7 days, assessed using the 11-point Numerical Pain Rating Scale. - Be a resident in Australia for the intervention and follow-up period. - Have access to the internet and smart device (e.g., mobile phone). - Be proficient in English. Exclusion Criteria: - Bilateral amputation. - Scheduled for major surgery during the study period. - Pain in the intact limb. - Vision impairment that would preclude successful participation. - Auditory impairment that would preclude successful participation. - Cognitive problems that would preclude effective participation in trial procedures (e.g., Alzheimer's, dementia). - Previously diagnosed neurological disorders that affect the movement of the intact limb (e.g., stroke, Parkinson, Multiple Sclerosis). - Completed Graded Motor Imagery in the order of left/right judgements, imagined movements, and mirror therapy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Progressive rehabilitation program
Twelve-week treatment program delivered via eight, up to 1-hour telehealth sessions. The first five sessions will be scheduled every week, and the final three sessions will be scheduled fortnightly. Participants will also be prescribed approximately 15-30 minutes of home activities daily. The treatment program includes pain science education, sensory training, implicit and explicit motor imagery, and mirror therapy. Participants will complete activities at a self-directed pace following a standard progression protocol. Participant adherence will be measured via session attendance and self-report therapy diaries.
Stimulation devices
Twelve-week treatment program delivered via eight, up to 1-hour telehealth sessions. The first five sessions will be scheduled every week, and the final three sessions will be scheduled fortnightly. Participants will also be prescribed approximately 15-30 minutes of home activities daily. The treatment program includes transcutaneous electrical nerve stimulation and cranial electrical stimulation. Participants will complete activities at a self-directed pace following a standard progression protocol. Participant adherence will be measured via session attendance and self-report therapy diaries.

Locations

Country Name City State
Australia Neuroscience Research Australia Randwick New South Wales

Sponsors (1)

Lead Sponsor Collaborator
Neuroscience Research Australia

Country where clinical trial is conducted

Australia, 

References & Publications (1)

Limakatso K, Cashin AG, Williams S, Devonshire J, Parker R, McAuley JH. The Efficacy of Graded Motor Imagery and Its Components on Phantom Limb Pain and Disability: A Systematic Review and Meta-Analysis. Can J Pain. 2023 May 17;7(1):2188899. doi: 10.1080/24740527.2023.2188899. eCollection 2023. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Pain Self-Efficacy Questionnaire (mediator) Pain self efficacy measured using the Pain Self-Efficacy Questionnaire. The total score of this questionnaire ranges from 0 to 60, with higher scores indicating higher self-efficacy and functioning despite ongoing pain. Weeks 6 and 10 post-randomisation
Other Concept of Pain Inventory (mediator) Beliefs and knowledge of pain science assessed using the Concept of Pain Inventory. This is a 13-item questionnaire with scores ranging from 0 to 52 points, with higher scores reflecting greater alignment with contemporary pain science. Weeks 6 and 10 post-randomisation
Other Pain Catastrophising Scale (mediator) Pain catastrophising assessed using the Pain Catastrophising Scale. The total score ranges from 0 to 52, with higher scores indicating a higher level of catastrophising. Weeks 6 and 10 post-randomisation
Other Phantom limb movement scale (mediator) The ability to move the phantom limb assessed on an 11-point Numerical Rating Scale (0: No movement at all, 10: Complete range of movement as if the limb were still present). Weeks 6 and 10 post-randomisation
Other Phantom limb body perception disturbance scale (mediator) The phantom limb body perception disturbances assessed using 4 questions measuring ownership, awareness, attention and emotional feelings on an 11-point Numerical Rating Scale (range, 0-40; lower scores indicate more severe body perception disturbances). Adapted from the Bath Complex Regional Pain Syndrome body perception disturbance scale. Weeks 6 and 10 post-randomisation
Primary Pain intensity Average pain intensity over the previous 7 days assessed using the 11-point Numerical Pain Rating Scale. Week 12 post-randomisation
Primary Pain interference Average pain interference with function over the previous 7 days assessed using the 0-10 Pain Interference Scale of the Brief Pain Inventory. Week 12 post-randomisation
Secondary Pain intensity Average pain intensity over the previous 7 days assessed using the 11-point Numerical Pain Rating Scale. Weeks 24 and 52 post-randomisation
Secondary Pain interference Average pain interference with function over the previous 7 days assessed using the 0-10 Pain Interference Scale of the Brief Pain Inventory. Weeks 24 and 52 post-randomisation
Secondary Pain severity Average pain intensity over the previous 7 days assessed using the 0-10 Pain Severity Scale of the Brief Pain Inventory. Weeks 12, 24 and 52 post-randomisation
Secondary Sleep subscale of the Brief Pain Inventory's Pain Interference Scale Sleep Quality assessed using the Sleep subscale of the Brief Pain Inventory's Pain Interference Scale. The participants will rate the interference of pain with sleep on a 0-10 scale where "0" represents "does not interfere" and "10" represents "completely interferes". Weeks 12, 24 and 52 post-randomisation
Secondary PROMIS Self-Efficacy Manage Symptoms Pain Self-efficacy assessed using PROMIS Self-Efficacy Manage Symptoms (Computer Adaptive Test) (28-item version; higher scores mean more self-efficacy). Weeks 12, 24 and 52 post-randomisation
Secondary PROMIS Depression Emotional distress and depression assessed using PROMIS Depression (Computer Adaptive Test) (28-item version; higher scores mean more depression). Weeks 12, 24 and 52 post-randomisation
Secondary EuroQol 5-Dimension 5-Level (EQ-5D-5L) Health-Related Quality of Life assessed using the EQ-5D-5L dimensions scale range, 1-5; higher scores indicate better quality of life) and health thermometer (range, 0-100; higher scores indicate better quality of life). Weeks 12, 24 and 52 post-randomisation
Secondary Global Perceived Effect Scale Perception of recovery assessed using the Global Perceived Effect scale (range from -5 to +5; higher scores mean greater improvement). Weeks 12, 24 and 52 post-randomisation
Secondary Adverse events Adverse events assessed via self-report. From randomisation to week 12 post-randomisation
Secondary Adherence to treatment Adherence to treatment assessed via session attendance and self-report (diary), including frequency per week and duration per day. From randomisation to week 12 post-randomisation
Secondary Total health-care costs Total health-care costs will be estimated as the trial intervention costs and outside trial health-care resource use attributable to phantom limb pain from the Medicare Benefits Scheme and Pharmaceutical Benefits Scheme. Quality-adjusted life-years (QALYs) from the EQ-5D-5L using the Australian utility weights will also be used in the trial-based cost-utility analysis. Weeks 12, 24 and 52 post-randomisation
Secondary Treatment rationale credibility Treatment rationale credibility assessed using the Credibility and Expectancy Questionnaire. The total score ranges from 0 to 48, with lower scores indicating lower credibility. Week 1 post-randomisation
See also
  Status Clinical Trial Phase
Recruiting NCT03947450 - Autologous Volar Fibroblast Injection Into the Stump Site of Amputees Phase 2
Completed NCT04924036 - Qbrexza Cloths for Hyperhidrosis of Amputation Sites Phase 2
Recruiting NCT04839497 - Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees. Phase 2
Recruiting NCT04212299 - Transfemoral Socket Design and Muscle Function N/A
Completed NCT03733054 - Understanding Prosthetic Needs and Outcomes in Women Veterans With Amputation
Completed NCT03651830 - A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations N/A
Recruiting NCT04725006 - Sensory Responses to Dorsal Root Stimulation N/A
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT04936789 - Clinical Feasibility of the IMES Transradial Prosthesis N/A
Completed NCT01155024 - Clinical Evaluation of Direct Manufactured Prosthetic Sockets Phase 2
Completed NCT00663663 - Telephone Intervention for Pain Study (TIPS) N/A
Terminated NCT00778856 - Hand Transplantation for the Reconstruction of Below the Elbow Amputations N/A
Recruiting NCT00388752 - Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation Phase 1
Active, not recruiting NCT03374319 - Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations N/A
Completed NCT05542901 - Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees N/A
Completed NCT05161364 - Kinetic Analysis Due to Foot Dysfunction
Recruiting NCT06194838 - Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees N/A
Completed NCT03570788 - HRQoL Among Patients Amputated Due to Peripheral Arterial Disease
Completed NCT05778799 - Physical Activity and Sports for People With Special Needs
Recruiting NCT04804150 - Daily Socket Comfort in Transtibial Amputee With an Active Vacuum Suspension System N/A

External Links